Life Sciences Commercializer - Thad Bench of Benchworks

Thad Bench, the CEO of Benchworks, grew his company's revenue from $8 million in 2014 to $42.4 million in 2017, a 428% increase, and to around $68 million in 2018.  

Benchworks is a fully integrated life sciences commercialization partner.  

In this interview with Eversprint's Malcolm Lui, Thad shares how he and his team accelerated their high value sales by:  

• Surrounding themselves with giants who have the skills their business needs.  
• Innovating on the entire spectrum of their services from marketing to distribution to technology.  
• Identifying and providing better services to under-served markets, such as smaller pharmacies.